BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25216742)

  • 1. ALCAM and CD6--multiple sclerosis risk factors.
    Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
    J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
    Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M
    J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
    Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
    Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
    Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
    J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6.
    Te Riet J; Helenius J; Strohmeyer N; Cambi A; Figdor CG; Müller DJ
    J Cell Sci; 2014 Apr; 127(Pt 7):1595-606. PubMed ID: 24496453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
    Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; de las Heras V; Barcina MG; Arroyo R; Alcina A; Fernandez O; Antigüedad A; Urcelay E; Vandenbroeck K
    J Neuroimmunol; 2010 Jun; 223(1-2):100-3. PubMed ID: 20430450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.
    Tudor C; te Riet J; Eich C; Harkes R; Smisdom N; Bouhuijzen Wenger J; Ameloot M; Holt M; Kanger JS; Figdor CG; Cambi A; Subramaniam V
    J Biol Chem; 2014 May; 289(19):13445-60. PubMed ID: 24662291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.
    Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; Fernández O; Lucas M; Orpez T; Pinto-Medel MJ; Otaegui D; Olascoaga J; Urcelay E; Ortiz MA; Arroyo R; Oksenberg JR; Antigüedad A; Tolosa E; Vandenbroeck K
    PLoS One; 2013; 8(4):e62376. PubMed ID: 23638056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
    Jurewicz A; Zaleski K; Domowicz M; Selmaj K
    J Neuroimmunol; 2014 Nov; 276(1-2):187-94. PubMed ID: 25242631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.
    Lyck R; Lécuyer MA; Abadier M; Wyss CB; Matti C; Rosito M; Enzmann G; Zeis T; Michel L; García Martín AB; Sallusto F; Gosselet F; Deutsch U; Weiner JA; Schaeren-Wiemers N; Prat A; Engelhardt B
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2894-2909. PubMed ID: 28273717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
    Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
    Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
    Mowry EM; Carey RF; Blasco MR; Pelletier J; Duquette P; Villoslada P; Malikova I; Roger E; Kinkel RP; McDonald J; Bacchetti P; Waubant E
    PLoS One; 2013; 8(10):e75416. PubMed ID: 24130709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD6 recognizes the neural adhesion molecule BEN.
    Skonier JE; Bowen MA; Aruffo A; Bajorath J
    Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
    da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
    J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
    Park TJ; Kim HJ; Kim JH; Bae JS; Cheong HS; Park BL; Shin HD
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):519-30. PubMed ID: 22994200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
    Kruize Z; Maurer I; Boeser-Nunnink BDM; Booiman T; Kootstra NA
    AIDS; 2020 Jul; 34(9):1303-1312. PubMed ID: 32287057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.